SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Andreasson F.) "

Sökning: WFRF:(Andreasson F.)

  • Resultat 1-10 av 118
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Elhai, M, et al. (författare)
  • Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
  • 2019
  • Ingår i: Annals of the rheumatic diseases. - : BMJ. - 1468-2060 .- 0003-4967. ; 78:7, s. 979-987
  • Tidskriftsartikel (refereegranskat)abstract
    • To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical practice.MethodsWe performed a prospective study including patients with SSc from the European Scleroderma Trials and Research (EUSTAR) network treated with rituximab and matched with untreated patients with SSc. The main outcomes measures were adverse events, skin fibrosis improvement, lung fibrosis worsening and steroids use among propensity score-matched patients treated or not with rituximab.Results254 patients were treated with rituximab, in 58% for lung and in 32% for skin involvement. After a median follow-up of 2 years, about 70% of the patients had no side effect. Comparison of treated patients with 9575 propensity-score matched patients showed that patients treated with rituximab were more likely to have skin fibrosis improvement (22.7 vs 14.03 events per 100 person-years; OR: 2.79 [1.47–5.32]; p=0.002). Treated patients did not have significantly different rates of decrease in forced vital capacity (FVC)>10% (OR: 1.03 [0.55–1.94]; p=0.93) nor in carbon monoxide diffusing capacity (DLCO) decrease. Patients having received rituximab were more prone to stop or decrease steroids (OR: 2.34 [1.56–3.53], p<0.0001). Patients treated concomitantly with mycophenolate mofetil had a trend for better outcomes as compared with patients receiving rituximab alone (delta FVC: 5.22 [0.83–9.62]; p=0.019 as compared with controls vs 3 [0.66–5.35]; p=0.012).ConclusionRituximab use was associated with a good safety profile in this large SSc-cohort. Significant change was observed on skin fibrosis, but not on lung. However, the limitation is the observational design. The potential stabilisation of lung fibrosis by rituximab has to be addressed by a randomised trial.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Henstrom, M., et al. (författare)
  • Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome
  • 2018
  • Ingår i: Gut. - : BMJ. - 0017-5749 .- 1468-3288. ; 67:2, s. 263-270
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective IBS is a common gut disorder of uncertain pathogenesis. Among other factors, genetics and certain foods are proposed to contribute. Congenital sucraseisomaltase deficiency (CSID) is a rare genetic form of disaccharide malabsorption characterised by diarrhoea, abdominal pain and bloating, which are features common to IBS. We tested sucrase-isomaltase (SI) gene variants for their potential relevance in IBS. Design We sequenced SI exons in seven familial cases, and screened four CSID mutations (p.Val557Gly, p. Gly1073Asp, p.Arg1124Ter and p.Phe1745Cys) and a common SI coding polymorphism (p.Val15Phe) in a multicentre cohort of 1887 cases and controls. We studied the effect of the 15Val to 15Phe substitution on SI function in vitro. We analysed p.Val15Phe genotype in relation to IBS status, stool frequency and faecal microbiota composition in 250 individuals from the general population. Results CSID mutations were more common in patients than asymptomatic controls (p=0.074; OR=1.84) and Exome Aggregation Consortium reference sequenced individuals (p=0.020; OR=1.57). 15Phe was detected in 6/7 sequenced familial cases, and increased IBS risk in case-control and population-based cohorts, with best evidence for diarrhoea phenotypes (combined p=0.00012; OR=1.36). In the population-based sample, 15Phe allele dosage correlated with stool frequency (p=0.026) and Parabacteroides faecal microbiota abundance (p=0.0024). The SI protein with 15Phe exhibited 35% reduced enzymatic activity in vitro compared with 15Val (p<0.05). Conclusions SI gene variants coding for disaccharidases with defective or reduced enzymatic activity predispose to IBS. This may help the identification of individuals at risk, and contribute to personalising treatment options in a subset of patients.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 118
Typ av publikation
tidskriftsartikel (98)
konferensbidrag (16)
rapport (3)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (94)
övrigt vetenskapligt/konstnärligt (24)
Författare/redaktör
Hajdu, Janos (19)
Zetterberg, Henrik, ... (15)
Andreasson, Jakob (15)
Blennow, Kaj, 1958 (14)
Andreasson, Ulf, 196 ... (14)
Timneanu, Nicusor (12)
visa fler...
Maia, Filipe R. N. C ... (11)
Samuelsson, J (10)
Andreasson, B (10)
Andreasson, Anna (10)
Andreasson, A (10)
Barty, Anton (10)
Seibert, M Marvin (9)
Svenda, Martin (9)
Ekeberg, Tomas (8)
Andreasson, Jakob, 1 ... (8)
Andreasson, S (7)
Zweegman, S (7)
Harrison, C (7)
Bielecki, Johan (7)
Chapman, Henry N. (7)
Bostedt, Christoph (7)
Johansson, P. (6)
Agreus, L (6)
Birgegård, Gunnar (6)
Andréasson, Sten (6)
Lindberg, G (6)
D'Amato, M (6)
Agréus, Lars (6)
Cervantes, F (6)
Besses, C (6)
Andersson, Inger (6)
Nettelblad, Carl (6)
Sun, X. (5)
Xu, Z. (5)
Lehmann, T. (5)
Zhang, P (5)
Xu, J (5)
Ferrari, M (5)
Reiter, A (5)
D'Amato, Mauro (5)
Chapman, H. N. (5)
Bostedt, C. (5)
Kirian, Richard A. (5)
DePonte, Daniel P. (5)
Liang, Mengning (5)
Stellato, Francesco (5)
Daurer, Benedikt J. (5)
Loh, N. Duane (5)
Andréasson, F. (5)
visa färre...
Lärosäte
Karolinska Institutet (44)
Uppsala universitet (33)
Göteborgs universitet (24)
Lunds universitet (19)
Chalmers tekniska högskola (17)
Kungliga Tekniska Högskolan (10)
visa fler...
Stockholms universitet (9)
Linköpings universitet (9)
Sveriges Lantbruksuniversitet (5)
Umeå universitet (4)
Örebro universitet (4)
Högskolan i Halmstad (2)
Linnéuniversitetet (2)
Luleå tekniska universitet (1)
Mittuniversitetet (1)
visa färre...
Språk
Engelska (118)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (54)
Naturvetenskap (38)
Teknik (5)
Lantbruksvetenskap (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy